EP1337 A Primary Extended Cytoreductive Surgery for Ovarian Cancer: Total Abdominal Hysterectomy and Bilateral Salpingo-Oophorectomy, Total Omentectomy, Total Peritonectomy, Bilateral Diaphragm Stripping, Cholecystectomy, Total Colectomy, Splenectomy, Bilateral Pelvic-Paraaortic Lymphadenectomy, Dissection of Porta Hepatis, Liver Metastasectomy, and Bilateral Cardiophrenic Lymphadenectomy

C. Taskiran,D. Vatansever,A. Eraslan,B. Giray,S. Misirlioglu,E. Balik,T. Kumcular,M. Arvas

DOI: https://doi.org/10.1136/ijgc-2019-esgo.1341

2019-01-01

Abstract:Introduction/Background Ovarian cancer is the leading cause of death among gynecological malignancies. Primary cytoreduction for ovarian cancer is associated with significantly improved survival. We aimed to present a primary extended cytoreduction performed in this video. Methodology A 37 years-old woman was admitted with abdominal swelling and pelvic pain. Pelvic examination revealed out ascites and bilateral adnexal masses. MRI showed 11-cm right adnexal mass, 7-cm left adnexal mass, omental cakes, disseminated peritoneal implants, liver metastases, and enlarged lymph nodes in the right obturator fossa. Total abdominal hysterectomy, bilateral salpingo-oophorectomy, total omentectomy, total peritonectomy, bilateral diaphragmatic stripping, total colectomy, splenectomy, bilateral pelvic-paraaortic lymphadenectomy, cholecystectomy, dissection of the porta hepatis, liver metastasectomy, and transabdominal cardiophrenic lymph node dissection were performed as a part of maximal primarily cytoreduction. Results We did not encounter any grade 3 or 4 adverse event in post-operative period. Conclusion Primary cytoreduction for ovarian cancer with no residual disease is a major impact on survival. The management of this condition should be performed with expert multidisciplinary teams in gynecological oncology. Disclosure Nothing to disclose